Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness

[1]  G. Bernard,et al.  Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome* , 2011, Critical care medicine.

[2]  D. Talmor,et al.  Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. , 2011, Chest.

[3]  P. Newman,et al.  Neutrophil Transmigration Mediated by the Neutrophil-Specific Antigen CD177 Is Influenced by the Endothelial S536N Dimorphism of Platelet Endothelial Cell Adhesion Molecule-1 , 2010, The Journal of Immunology.

[4]  M. Bauer,et al.  Antiplatelet drugs and outcome in mixed admissions to an intensive care unit* , 2010, Critical care medicine.

[5]  T. Voyno-Yasenetskaya,et al.  Lipopolysaccharide Stimulates Platelet Secretion and Potentiates Platelet Aggregation via TLR4/MyD88 and the cGMP-Dependent Protein Kinase Pathway1 , 2009, The Journal of Immunology.

[6]  P. Gurbel,et al.  Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting. , 2009, The American journal of cardiology.

[7]  A. Weyrich,et al.  Amicus or adversary: platelets in lung biology, acute injury, and inflammation. , 2009, American journal of respiratory cell and molecular biology.

[8]  M. Bauer,et al.  Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms , 2009, Platelets.

[9]  S. Pitchford.  Novel uses for anti‐platelet agents as anti‐inflammatory drugs , 2007, British journal of pharmacology.

[10]  Deepak L. Bhatt,et al.  Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease , 2007, Vascular medicine.

[11]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Raghu Kacker,et al.  Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.

[13]  J. Freedman,et al.  Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. , 2006, Blood.

[14]  E. Scheuermann,et al.  Anti‐inflammatory effects of clopidogrel intake in renal transplant patients: Effects on platelet‐leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers , 2005, Clinical pharmacology and therapeutics.

[15]  P. Kubes,et al.  Platelets express functional Toll-like receptor-4. , 2005, Blood.

[16]  P. Savi,et al.  Clopidogrel inhibits platelet-leukocyte adhesion and plateletdependent leukocyte activation , 2005, Thrombosis and Haemostasis.

[17]  W. Thompson,et al.  The Burden of Community-Acquired Pneumonia in Seniors: Results of a Population-Based Study , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  T. van der Poll,et al.  Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. , 2004, The Journal of infectious diseases.

[19]  C. A. de la Motte,et al.  Cutting Edge: T Cells Trigger CD40-Dependent Platelet Activation and Granular RANTES Release: A Novel Pathway for Immune Response Amplification1 , 2004, The Journal of Immunology.

[20]  S. Harder,et al.  Clopidogrel but not aspirin reduces P‐selectin expression and formation of platelet‐leukocyte aggregates in patients with atherosclerotic vascular disease * , 2003, Clinical pharmacology and therapeutics.

[21]  K. Reinhart,et al.  Platelet and Leukocyte Activation Correlate with the Severity of Septic Organ Dysfunction , 2002, Shock.

[22]  D. Dixon,et al.  Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis , 2001, The Journal of cell biology.

[23]  K. Ley,et al.  RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium , 2001, Circulation.

[24]  K. Schrör,et al.  Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel , 2001, Platelets.

[25]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[26]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[27]  T. Springer,et al.  Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. , 1996, Blood.

[28]  M. Gawaz,et al.  Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure , 1995, European journal of clinical investigation.

[29]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[30]  白木 里織.  Expression of Toll-like receptors on human platelets , 2005 .

[31]  M. Lynn.  Instrument reliability and validity: how much needs to be published? , 1989, Heart & lung : the journal of critical care.